Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market | Industry Overview, Growth Rate, Trends Opportunities and Forecast 2027

Your avatar
Kathie Bryant

Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Type (Jardiance (Empagliflozin), Suglat (Ipragliflozin), Invokana (Canagliflozin), Farxiga/Forxiga (Dapagliflozin)) Application (Medical Research Institute, Hospital) – Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. SGLT2 is a part of the sodium-glucose cotransporter family which are glucose transport proteins that are sodium-dependent. SGLT2 is the main cotransporter included in reabsorption of glucose in the kidney. The growing global type-2 diabetes population promotes the growth of SGLT2 drugs.

Request to Fill The Form To get Sample Copy of This Report:

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Janssen Pharmaceuticals
Eli Lilly
Kotobuki Pharmaceutical
Boehringer Ingelheim
Bristol Myers Squibb

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Table of Content

1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2016-2027)
4.1.2. Canada Market Status and Outlook (2016-2027)
4.1.3. Mexico Market Status and Outlook (2016-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2016-2027)
4.2.2. France Market Status and Outlook (2016-2027)
4.2.3. UK Market Status and Outlook (2016-2027)
4.2.4. Russia Market Status and Outlook (2016-2027)
4.2.5. Italy Market Status and Outlook (2016-2027)
4.2.6. Rest of Europe Market Status and Outlook (2016-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2016-2027)
4.3.2. Japan Market Status and Outlook (2016-2027)
4.3.3. Korea Market Status and Outlook (2016-2027)
4.3.4. India Market Status and Outlook (2016-2027)
4.3.5. Southeast Asia Market Status and Outlook (2016-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2016-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2016-2027)
4.4.2. Argentina Market Status and Outlook (2016-2027)
4.4.3. Columbia Market Status and Outlook (2016-2027)
4.4.4. Rest of South America Market Status and Outlook (2016-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2016-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2016-2027)
4.5.3. Egypt Market Status and Outlook (2016-2027)
4.5.4. Nigeria Market Status and Outlook (2016-2027)
4.5.5. South Africa Market Status and Outlook (2016-2027)
4.5.6. Turkey Market Status and Outlook (2016-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2016-2027)
5. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, By Type
5.1. Introduction
5.2. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Type (2016-2019)
5.2.1. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Revenue Share by Type (2016-2019)
5.3. Jardiance (Empagliflozin)
5.3.1. Global Jardiance (Empagliflozin) Revenue and Growth Rate (2016-2019)
5.4. Suglat (Ipragliflozin)
5.4.1. Global Suglat (Ipragliflozin) Revenue and Growth Rate (2016-2019)
5.5. Invokana (Canagliflozin)
5.5.1. Global Invokana (Canagliflozin) Revenue and Growth Rate (2016-2019)
5.6. Farxiga/Forxiga (Dapagliflozin)
5.6.1. Global Farxiga/Forxiga (Dapagliflozin) Revenue and Growth Rate (2016-2019)

Request to Fill The Form To get Sample Copy of This Report:

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Some of the key questions answered by the report are:

What was the market size in 2016 and forecast from 2020 to 2027?
What will be the industry market growth from 2016 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Keep discovering on Mamby:

If you liked this post, you may also be interested in...
Information Work with us Contact Terms and Conditions FAQs
© 2021, Mamby Investments